Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
102625-70-7	Pantoprazole COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC	C₁₆H₁₅F₂N₃O₄S	383.4	98%	Click to inquire
1034616-18-6	Onvansertib CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO	C₂₄H₂₇F₃N₈O₃	532.5	99%	Click to inquire
1038915-73-9	Niraparib tosylate CC1=CC=C(C=C1)S(=O)(=O)O.C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N	C₂₆H₂₈N₄O₄S	492.6	99%	Click to inquire
1047644-62-1	Afuresertib CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl	C₁₈H₁₇Cl₂FN₄OS	427.3	98%	Click to inquire
1047953-91-2	2-Chloro-N-(4-(5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl)phenyl)acetamide COCCOC1=NN(C(=N1)C2=CC(=C(C=C2)Cl)Cl)C3=CC=C(C=C3)NC(=O)CCl	C₁₉H₁₇Cl₃N₄O₃	455.7	99%	Click to inquire
1051375-19-9	Dolutegravir Sodium CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]	C₂₀H₁₈F₂N₃NAO₅	441.4	97%	Click to inquire
1052532-15-6	SBE13 hydrochloride COC1=C(C=C(C=C1)CCNCC2=CC(=C(C=C2)OCC3=CN=C(C=C3)Cl)OC)OC.Cl	C₂₄H₂₈Cl₂N₂O₄	479.4	98%	Click to inquire
1062243-51-9	4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC	C₂₇H₃₅F₂N₇O₃	543.6	99%	Click to inquire
106362-34-9	Dapta CC(C(C(=O)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(C)N)O	C₃₅H₅₆N₁₀O₁₅	856.9	98%	Click to inquire
1071992-99-8	Xevinapant CC(C)CC(=O)N1CCC2CCC(N2C(=O)C(C1)NC(=O)C(C)NC)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4	C₃₂H₄₃N₅O₄	561.7	98%	Click to inquire

C₁₆H₁₅F₂N₃O₄S 383.4

C₂₄H₂₇F₃N₈O₃ 532.5

Niraparib tosylate

MK-4827 (tosylate)

C₂₆H₂₈N₄O₄S 492.6

C₁₈H₁₇Cl₂FN₄OS 427.3

2-Chloro-N-(4-(5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl)phenyl)acetamide

MI 2 (MALT1 inhibitor)

C₁₉H₁₇Cl₃N₄O₃ 455.7

Dolutegravir Sodium

Dolutegravir (sodium)

C₂₀H₁₈F₂N₃NAO₅ 441.4

SBE13 hydrochloride

SBE13 (Hydrochloride)

C₂₄H₂₈Cl₂N₂O₄ 479.4

4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide

C₂₇H₃₅F₂N₇O₃ 543.6

(D-ALA1)-PEPTIDE T AMIDE

C₃₅H₅₆N₁₀O₁₅ 856.9

C₃₂H₄₃N₅O₄ 561.7

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15070) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号